Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30803748 | 0.86 | ELANE (0.56) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL1232932 | 0.86 | ELANE (0.56) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL30803750 | 0.86 | ELANE (0.56) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL459655 | 0.82 | PTGS2 (0.57) | TDP1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL9453584 | 0.80 | ELANE (0.56) | ELANETDP1ALDH1A1KDM4EHPGD | |
| SCHEMBL8962026 | 0.80 | ELANE (0.51) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL10399814 | 0.80 | ELANE (0.51) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL14173261 | 0.80 | ELANE (0.51) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL30007261 | 0.80 | ELANE (0.51) | ELANETDP1ATMALDH1A1KDM4E | |
| SCHEMBL650229 | 0.78 | ELANE (0.50) | ELANETDP1ATMALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850564-B | Photosensitive alkali developing resin and preparation method and application thereof | 广东三求光固材料股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-115850564-A | Photosensitive alkali developing resin and preparation method and application thereof | 广东三求光固材料股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-115850564-B | Photosensitive alkali developing resin and preparation method and application thereof | 广东三求光固材料股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-115850564-A | Photosensitive alkali developing resin and preparation method and application thereof | 广东三求光固材料股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-6794471-B2 | OF A HYDROXYHYDROCARBYL- OR MERCAPTOHYDROCARBYL- DITHIOLANE; CURED OPTICAL ARTICLE FORMED BY PHOTOPOLYMERIZING THE ACRYLATE | MITSUI CHEMICALS, INC. (JP) | 2004-09-21 | — | — | US | disclosed |
| US-20020061995-A1 | Acrylic ester compound and usage thereof | MITSUI CHEMICALS, INC. (JP) | 2002-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061995-A1 | Acrylic ester compound and usage thereof | ASS1, HAT1, EIF2B1 | ELANE 538/4885TDP1 3096/4885ATM 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.